Given that c-Myc is a key regulator of cell proliferation and biosynthetic activity in acute myeloid leukemia (AML), its suppression likely contributes to the inhibition of cell cycle progression, cholesterol biosynthesis, and pro-survival signaling. The gene discussed is MYC; the disease is acute myeloid leukemia.